S. Strauch

Are counterfeit or substandard anti-infective products the cause of treatment failure in Papua New Guinea?

J. Dressman, R. Jähnke, A. Nair, 2011, Journal of pharmaceutical sciences.

Comparison of WHO and US FDA biowaiver dissolution test conditions using bioequivalent doxycycline hyclate drug products

J. Dressman, E. Jantratid, S. Strauch, 2009 .

Biowaiver monographs for immediate release solid oral dosage forms: quinidine sulfate.

D. Barends, J. Polli, H. Junginger, 2009, Journal of pharmaceutical sciences.

Biowaiver monographs for immediate release solid oral dosage forms: lamivudine.

D. Barends, H. Junginger, S. Stavchansky, 2011, Journal of pharmaceutical sciences.

Biowaiver monographs for immediate release solid oral dosage forms: mefloquine hydrochloride.

D. Barends, H. Junginger, S. Stavchansky, 2011, Journal of pharmaceutical sciences.

The biowaiver procedure: its application to antituberculosis products in the WHO prequalification programme.

J. Dressman, M. Stahl, E. Jantratid, 2011, Journal of pharmaceutical sciences.

Comparison of WHO and US FDA biowaiver dissolution test conditions using bioequivalent doxycycline hyclate drug products.

J. Dressman, E. Jantratid, S. Strauch, 2009, The Journal of pharmacy and pharmacology.

Biowaiver monographs for immediate release solid oral dosage forms: Doxycycline hyclate.

D. Barends, G. Amidon, H. Junginger, 2010, Journal of pharmaceutical sciences.